A rebuttal to: A letter to editor entitled: "A panel (CA19-9, CEA and PIVKA-II) of serum markers for pancreatic cancer diagnosis" [0.03%]
对题为“胰腺癌诊断（CA19-9、CEA和PIVKA-II）血清标记物联合检测”的编辑来信的反驳
Meifang Wang,Deliang Cao
Meifang Wang
Myocardial damage in a 4-year old who ingested bisoprolol and hydrochlorothiazide - Incidental CK-BB highlighted other tissue toxicity [0.03%]
一名服用比索洛尔和氢氯噻嗪的4岁男孩出现心肌损伤病例-CK-MB升高提示其他组织毒性损伤
Tiziana Zangardi,Sara Altinier,Monica Maria Mion et al.
Tiziana Zangardi et al.
Introduction: A 4-year-old girl accidentally ingested an unknown quantity of bisoprolol (2.5 mg)-hydrochlorothiazide (6.25 mg) pills. Initialy asymptomatic, laboratory testing revealed elevated concentrations of cardiac a...
Clinical relevance of the Maglumi immunoassay for anti-GAD65 in diabetes and neurological disorders: Analytical challenges and diagnostic insights [0.03%]
磁酶免疫测定法检测GAD65自身抗体在糖尿病和神经疾病中的临床意义：分析挑战与诊断价值
Gonzalo Verdú,Antonio Jesús Blanco-Carrasco,Raquel Ruiz-García et al.
Gonzalo Verdú et al.
Introduction: Anti-GAD65 is an established diagnostic biomarker for autoimmune diabetes and neurological syndromes associated with GAD antibody-spectrum disorders. Automated chemiluminescence-based immunoassays such as Ma...
Optimizing the indeterminate zone for the DiaSorin LIAISON H. Pylori stool antigen test [0.03%]
优化DiaSorin LIAISON幽门螺杆菌粪便抗原检测的不确定区
Natalia Volodko,Mathew Estey,Dustin Proctor et al.
Natalia Volodko et al.
Introduction: Helicobacter pylori (H. pylori) colonization increases the risk of upper gastrointestinal disorders and can be detected by various tests, including the stool antigen test (HpSAT). DiaSorin recommends an HpSA...
Corrigendum to "CA19-9, CEA and PIVKA-II as a novel panel of serum markers for diagnosis of pancreatic cancer" [Clin. Biochem. 137 (2025) 110902] [0.03%]
关于“用于诊断胰腺癌的新型血清标志物CA19-9、CEA和PIVKA-II”[Clin. Biochem. 137 (2025) 110902]的勘误表
Meifang Wang,Hongying Bu,Weijia Luo et al.
Meifang Wang et al.
Published Erratum
Clinical biochemistry. 2025 Sep 30:111017. DOI:10.1016/j.clinbiochem.2025.111017 2025
Establishing indicators to monitor the utilization of POC glucose meters in glycemic control [0.03%]
建立指标以监测即时血糖仪在血糖控制中的使用情况
Yun Huang,Brendan Ly
Yun Huang
Objectives: The use of point-of-care (POC) glucose meters and effectiveness of glycemic control should be monitored as part of quality assurance practices. This study is the first to establish indicators to evaluate the u...
Katie M Troike,Adam J McShane
Katie M Troike
Background: Iron deficiency (ID) and iron deficiency anemia (IDA) are prevalent and treatable conditions which disproportionately affect women. Serum ferritin is the most sensitive biomarker for ID and IDA, but its utilit...
Timothy Ming Him Yeung,Elaine Yi Ling Wong,Melody Yee Man Wong et al.
Timothy Ming Him Yeung et al.